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Abstract
Radiotherapy based on magnetic resonance imaging as the sole modality (MRI-only RT) is an area of growing scientific
interest due to the increasing use of MRI for both target and normal tissue delineation and the development of MR
based delivery systems. One major issue in MRI-only RT is the assignment of electron densities (ED) to MRI scans
for dose calculation and a similar need for attenuation correction can be found for hybrid PET/MR systems. The
ED assigned MRI scan is here named a substitute CT (sCT). In this review, we report on a collection of typical
performance values for a number of main approaches encountered in the literature for sCT generation as compared to
CT. A literature search in the Scopus database resulted in 254 papers which were included in this investigation. A final
number of 50 contributions which fulfilled all inclusion criteria were categorized according to applied method, MRI
sequence/contrast involved, number of subjects included and anatomical site investigated. The latter included brain,
torso, prostate and phantoms. The contributions geometric and/or dosimetric performance metrics were also noted.
The majority of studies are carried out on the brain for 5–10 patients with PET/MR applications in mind using a voxel
based method. T1 weighted images are most commonly applied. The overall dosimetric agreement is in the order of
0.3–2.5%. A strict gamma criterion of 1% and 1mm has a range of passing rates from 68 to 94% while less strict criteria
show pass rates > 98%. The mean absolute error (MAE) is between 80 and 200 HU for the brain and around 40 HU for
the prostate. The Dice score for bone is between 0.5 and 0.95. The specificity and sensitivity is reported in the upper
80s% for both quantities and correctly classified voxels average around 84%. The review shows that a variety of
promising approaches exist that seem clinical acceptable even with standard clinical MRI sequences. A consistent
reference frame for method benchmarking is probably necessary to move the field further towards a widespread
clinical implementation.
Introduction
Dose calculations performed on scans from magnetic
resonance imaging (MRI) were first reported around the
millennium when MRI emerged as a complimentary
modality to computed tomography (CT) in the delinea-
tion step of the radiotherapy (RT) chain [1, 2]. As MRI
provides superior soft tissue contrast and delineation
precision as compared to CT [3–8], the concept of
carrying out all steps of the RT chain on MRI as the sole
modality, so-called MRI-only RT, could provide a favorable
workflow. MRI-only RT would further remove a systematic
registration error when transferring MRI delineated struc-
tures to the CT which has been reported to be in the order
of 2–5 mm for various treatment sites [9–13]. As CT is
used for positioning of the patient at treatment, registra-
tion errors introduce a spatial systematic uncertainty. The
dosimetric impact of a systematic error will increase when
the radiation is aimed at small structures or when the
target is close to sensitive organs. This could be the case
for small tumors or the hippocampus in the brain [14] with
a structure radius in the order of a possible registration
error or when a standard PTV or PRV margin has to be
compromised to maintain an acceptable therapeutic ratio.
An example of the MRI to CT registration variability for a
prostate and nasopharynx case is illustrated in Fig. 1.
In addition, MRI-only will decrease the number of
scans and associated patient discomfort, and, reduce the
planning related costs [15]. The benefits of MRI-only
RT would further increase in a workflow with repeated
imaging, e.g. weekly scans, for response assessment
and/or treatment adaptation.
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A number of concerns related to MRI-only RT exist.
One major challenge of performing dose calculations on
MRI is the lack of correspondence between the voxel
intensity and the associated attenuation property of the
tissue. Unlike CT images where the voxel intensity directly
reflects the radiological characteristics of the tissue, MRI
intensities rather correlate with tissue proton density and
the magnetic relaxation, i.e. the inertia of the dipole
moment [16]. This leads to voxel ambiguity for tissues
such as bone and air which both appear dark on the MRI
although they have very different attenuation coefficients.
The focus of this review is strategies for dealing with this
ambiguity. Further challenges constitute scanner induced
geometrical distortions arising from gradient non-linearity
and magnet inhomogeneities and patient induced artifacts
such as susceptibility and chemical shifts [13]. Specific
problems for algorithms converting the MRI signal into a
CT number further constitute normalization of absolute
signal intensities and data correction strategies such as
bias field correction. These topics are considered out of
scope of this review.
The increased use of MRI for target and normal tissue
delineation in RT in general and two device-driven
events have facilitated scientific activity for assigning
electron densities to MRI images1. The first event is the
commercial availability of clinical integrated hybrid PET/
MRI systems around 2010-2011 [17]. Unlike traditional
PET/CT systems where the CT scan is used for attenuation
correction of the PET signal needed in quantitative PET
volume estimates such as the standard uptake volume
(SUV), attenuation coefficients need to be assigned to the
MRI scan in hybrid PET/MRI systems to make a similar
attenuation correction. The second event is the com-
mercial availability of integrated MRI guided systems in
external beam RT around 2014 [18]. These systems can
provide MRI scans for patient setup based on soft tissues
and monitor the tumor movement during treatment
delivery. The systems would be able to calculate and
Fig. 1 Variability of multiple registrations between MRI and the corresponding CT for prostate (top) and nasopharynx (bottom). a: One marker
(of three) indicated by a white circle on the axial MRI. b: Two markers shown by the white dots on the sagittal CT. The multiple thin white lines
are the MRI delineated clinical target volume (CTV) transferred to the CT based on the marker registration following department protocol from
7 different observers. The protocol is based on a rigid automatic (mutual information) registration for a limited FOV around the prostate followed
by a manual adjustment to match the markers in the three planes. The outermost white line was the planned target volume (PTV) applied. The
data are taken from reference [59]. c: The gross target volume (inner) and CTV (outer) as delineated on the axial MRI. d: The multiple thin white
lines are the MRI based CTV transferred to the CT by 6 different observers (sagital CT slice shown). The registration is based on a rigid automatic
(mutual information) registration followed by a manual fine adjustment. The outermost white line was again the applied PTV. The data are taken
from reference [60]
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adapt the dose distribution at each given fraction if a
dose calculation can be performed on the MRI scan
which requires electron densities to be assigned. The
increased focus on MRI in RT and the introduction of
the imaging and treatment devices is reflected in the
number of publications as illustrated in Fig. 2.
In this review, we will report on a collection of typical
performance values for a number of main approaches
encountered in the literature for conversion of MR data
to electron density or HU maps relevant for RT. The
generated map is called “synthetic CT”, “substitute
CT”,”pseudo CT” or similar, i.e. no common terminology
is currently established. In the following, we will use the
term substitute CT (sCT) since the acronym for pseudo
CT (pCT) is often used for the planning CT in adaptive
RT studies [19, 20]. This field of research covers both
diagnostic and therapeutic radiology as well as MRI.
Further, the research field expands into automatic organ
segmentation and image analysis in general. As a result, a
diverse amount of approaches with different scientific
traditions, terminology and endpoints in mind have been
reported in the literature. Consequently, we have had to
make simplifications and compromise details in order to
preserve an overview and to further categorize and score
the methods with the aim of providing results relevant for
RT. Therefore, a direct comparison between the reported
performance metrics presented here is not valid. Rather,
the idea is to provide an overview of the multiple strat-
egies investigated in the literature along with a general
order of accuracy that can be reached.
We have categorized the investigated methods into
three main approaches. These are termed voxel [21–23],
atlas [24, 25] and hybrid [26, 27]. The latter use a com-
bination of the voxel and atlas based approach. Similar
approaches are typically categories as segmentation,
sequence/image contrast, template and atlas in PET/
MRI terminology [16, 28]. The voxel based approach
primarily uses information about voxel intensities (con-
trasts) in the MR images to assign electron densities.
No or limited information about the location of voxels is
included in this category. The voxel based methods are
dominated by the concept of machine learning in which
Fig. 2 The number of articles versus time after applying the search string and exclusion criterion 1 provided in the text. The publications are
grouped into proposed applications of the described method and sorted according to publication year. A boost in the amount of publications
can be inspected around 2010 (PET/MRI) and 2013-14 (MRI guided EBRT)
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part of the data is used to train (optimize) a model which
is then applied on the remaining MRI data to predict the
CT numbers. If a study contains n patients, this is usually
done by training the model on n-1 patients and then
predict the sCT on the remaining patient in a rotating
scheme known as leave-one-out cross validation. The
electron density assignment (CT number) can be made on
the basis of generic values (e.g. from ICRU report 46 [29])
to bulk groups of voxels. Alternatively, the assignment can
happen on a continuous scale by including patient specific
CT numbers in a training phase. In contrast, the atlas
based approaches focus on aligning the location of a
patients MRI voxels to the corresponding location of a
MRI voxels in an atlas through registration. The atlas can
either be a single or average (template) patient or contain
a number of patients (often termed multi-atlas). The atlas
contains a pre-known correlation between the MRI voxels
and the value of interest, e.g. CT number or organ label.
Once the alignment has taken place, the atlas CT number
can be assigned to the patients’ MRI scan and hence con-
verting it into a sCT scan.
A large number of MRI sequences/contrasts for electron
density assignment have been reported in the literature.
We have chosen to divide the MR input images into four
main contrasts / sequences categories. The first two
categories are simply termed T1 weighted (T1w) and T2
weighted (T2w). They are based on common clinical MRI
sequences which rely on either the longitudinal (T1) or the
transverse (T2 or T2*) tissue relaxation to produce image
contrast. The T1 and T2 relaxation is determined from
multiple refocusing pluses during the repetition time while
T2* describes the relaxation of the free induction decay
(FID) produced in the receiver antenna coil. Two main
pulse sequences exist for MR image acquisition: spin echo
(SE) and gradient echo (GE). The SE MR signal intensity is
roughly proportional to ρ[1-exp(TR/T1)]exp(-TE/T2)
where ρ (proton density), T1 and T2 are tissue properties
and TR (repetition time) and TE (echo time) are sequence
parameters. The equation is only valid if TR > > TE which
is usually the case, and, in general T1 > T2 > T2* relaxation
[30]. T1w images (short TR, short TE) are preferred for
visualizing anatomy while T2w images (long TR, long TE)
are usually the choice for visualizing pathology. The third
category comprises the Dixon family of fat-water separat-
ing sequences and is collectively termed Dixon [31]. It is
based on the chemical shift between the resonance
frequencies of fat and water and can be weighted towards
T1, T2 or ρ as it is (typically) a SE sequence. The fourth
category of MRI sequences is based on dual ultrashort
echo time (dUTE) to visualize solid structures with a very
short T2 relaxation time such as the bone [32, 33]. In
dUTE image acquisition, a first signal is collected right
after the excitation, and a second using the GE technique at
a longer nominal echo-time. The first image is ρ weighted
or T1w depending on the flip-angle and the second will
have a T2*w or T1w contrast depending on the echo-time
and the flip-angle. T2* is only possible to realize with
gradient echo sequences.
Material and methods
Literature search
This review reports on a collection of typical performance
values for substitute CT generation rather than giving a
detailed theoretical background of the methods used to
predict substitute CT. To give a fair representation on the
scientific activity within this field, we performed a litera-
ture search in the Scopus database November 2015 [34].
Index terms such as Medical Subject Headings (MeSH)
terms were not used to define a search due to the wide
diversity of sciences involved in the research field and
the consequent lack of common terminology. Instead, a
collection of common keywords found in a number of
MRI-only RT and PET/MRI articles were organized in a
logical search string defining the inclusion criteria:
 TITLE-ABS-KEY [(“PET MRI” OR “MR PET”) AND
NOT (functional OR diffusion OR fdg-spect)]
OR
 TITLE-ABS-KEY [(radiotherapy OR “radiation
therapy”) AND (“magnetic resonance imaging” OR
“magnetic resonance” OR mri OR mr) AND NOT
chemotherapy]
AND
 TITLE-ABS-KEY [“Attenuation correction” OR
“computed tomography substitute” OR “substitute CT”
OR “pseudo CT” OR “MRI only” OR “MRI alone”]
where TITLE-ABS-KEY indicate either the title, abstract
or keywords of the paper. This resulted in 254 papers
and we further added 7 papers/abstracts that for various
reasons were not found in the structured literature
search (e.g. strange keywords, conference abstracts etc.).
Three exclusion steps were then introduced. Exclusion 1
was defined as papers having TITLE-ABS-KEY on the
following:
 Diagnostics and delineations based on MRI only.
 Brachytherapy
 CT to MRI registration error/IGRT studies
 Subjects specific for PET/MRI: field-of-view (FOV)
truncation, effects of headphone and coils, etc.
 PET/MRI specific corrections: time-of-flight, line
source, maximum likelihood for attenuation and
activity (MLAA).
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The application of exclusion 1 reduced the number of
papers to 117. These included relevant investigations for
assigning electron densities to MRI scans for the pur-
pose of PET attenuation correction, MRI-only RT or
both (see Fig. 2). Exclusion 2 intended to only include
studies which presented novel methods for electron
density assignment. Abstracts and manuscripts includ-
ing the following were excluded:
 Review articles
 Book series or only insufficient abstracts available.
 RT feasibility/comparative studies: Dose calculations
incl. and excl. CT transferred structures such as
bone and air cavities to the MRI. CT bulky assigned
density vs. normal CT etc.
 PET/MRI feasibility/comparative studies: Difference
in SUV or similar by applying CT based vs. MRI
corrected attenuation maps incl. or excl. CT
transferred structures.
 Focus on MRI artifacts and distortion
quantifications and corrections.
 MRI-only based workflow descriptions.
After exclusion 2, 73 papers presenting novel correc-
tion methods remained (see Fig. 3). Whenever multiple
method approaches and /or MRI sequences were used
these were collectively categorized as “hybrid” and “mul-
tiple”, respectively.
Exclusion 3 intended to only consider studies which
included a quantitative performance metric of the resulting
sCT scan which would be relevant or applicable for RT
purposes. The following papers were excluded:
 No reported quantitative performance metric.
 Reported performance metric not relevant to
MRI-only RT, e.g. differences in SUV, linear
correlation coefficients of activity estimates, etc.
The final 50 papers are shown in Table 1 and the
selection process is summarized in Fig. 4. The final
papers were arranged in the main categories as described
in the introduction and further subcategorized within each
Fig. 3 Categorization of contributions after applying exclusion criterion 2. The papers were sorted according to their main method (left), used
MRI sequences/contrasts (middle) and number of subjects, i.e. phantom, patients or volunteers (right). In the above categories, the following
simplifications were made: head = brain, whole body = torso, cervix = prostate (only 1 study), UTE = dUTE, and water/fat separating MRI
sequences = Dixon. Volunteers and phantoms were categorized as patients. Some papers included description of multiple methods which
were included in the histograms as separate studies, hence the term “published studies” for the ordinate
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main approach and applied MRI sequences when possible.
The latter was limited to the four overall sequence
categories.
Method categories
The methods were organized with subcategories ac-
cording to a main voxel, atlas or hybrid approach in
Table 1. Voxel based sCT generation utilizes the con-
trast in the MR image independently of the voxels
spatial location. This makes it a potential computa-
tional attractive approach. The voxels can be con-
verted into CT numbers in multiple ways which we
have subcategorized below.
Semi-automatic refers to some kind of manual inter-
vention from the user to make the method work, e.g.
delineation of the bone or manually established inten-
sity thresholds below/above which a voxel is categorized
into a certain tissue category. Threshold covers methods
which use the tissue relaxation constant to differentiate
between different tissues. For the dUTE sequence/
contrast, the T2 relaxation time of the bone (0.5–2 ms
depending on magnetic field strength) can as an example
be used to categorize voxel which decays > 1/(0.5–2 ms)
into bone and voxels which remain constant (or decay
slowly) over the short acquisition time into soft tissue [35].
Probabilistic refers to methods which can assign a probabil-
ity of a voxel to belong to different tissue classes with e.g. a
corresponding bulk electron density (sCT) or organ label
(auto contouring). This could be done by assuming that
the MR intensities come from a mixture of K normal
distributions (tissue classes) with a corresponding mean
and standard deviation. The initial mixture can be
estimated with an expectation maximization algorithm
through unsupervised training, i.e. an electron density
(CT number) is assigned to each tissue class subsequently.
For each voxel, a probability can then be calculated for all
tissue classes and the voxel can be assigned to the tissue
class for which the highest probability was calculated. This
Fig. 4 The adopted strategy for inclusion of papers with reported metrics in this review
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is known as Bayesian statistics. Markow Random Fields
include the tissue classes of neighbor voxels in the
probability calculation of a given voxel [22]. Fuzzy c-
means clustering use a similar strategy of dividing the
MRI voxels into distinct clusters (tissue classes). Cluster
similarity coefficients are then calculated for each voxel
which is then assigned to the tissue which it resembles the
most. A number of different similarity measures exist.
Regression collects methods which correlate MRI inten-
sities to CT numbers through (statistical) regression on
a continuous scale. This can be done in a fashion simi-
lar to the Bayesian approach here termed Gaussian by
including co-registered CT intensities in an initial super-
vised training phase of the data that establish the prior
mixture of the K tissue classes [23]. Discriminant analysis,
Principal Component Analysis and Random Forest are
other strategies of performing such a regression between
MR and corresponding CT data. Sinogram use a for-
ward projection CT like approach to transform the MRI
scan into raw MR data where the different tissues are sub-
sequently identified. Neural network describes supervised
training of a correlation model in a hidden layer with an
MRI input layer and a CT output layer. Pattern recognition
in a voxel setting compares an MRI pattern, e.g. a cluster
of 3x3x3 size MR voxels known as a patch, with a pre-
established correlation between MR patterns and CT num-
bers obtained through supervised training. Different mea-
sures for pattern similarity can be used such as the
(normalized intensity) Euclidean distance. Hybrid voxel
methods combine a voxel based method with somewhat
loose information of the voxels location, e.g. distance
from center of the brain.
Atlas based sCT generation use the location of an MRI
voxel to establish the corresponding CT number by
aligning the voxel to an atlas with a pre-known correlation
between the MRI voxel location and corresponding CT
number. This is potentially more computational chal-
lenging as each patient's MRI has to be aligned with an
atlas with no possibility of exploiting a pre-training
model (except for the atlas building). In an atlas setting,
Pattern Recognition compares similarities of patient
MRI patches (see above) with atlas MRI patches within
a limited search volume after alignment. Deformable
refers to methods which use deformable registration,
i.e. non-rigid registration, to assign CT numbers from
an atlas to a given MRI scan. The patient's MRI is first
registered non-linearly with the atlas MRI. This could
be one registration if the atlas consists of one average
or template patient. Otherwise, the MRI has to be indi-
vidually registered to all MRIs in a multi-atlas which is
computationally less attractive. Alternative, one can set-
tle with one (entrance) registration if the multi-atlas is
internally registered, i.e. a registration map between the
entrance atlas and the other atlases has been pre-
established. The deformation map between the patient
and atlas MRI is then applied to the corresponding
atlas CT and the sCT produced. If multiple atlases are
used, a fused CT number can be applied.
Hybrid atlas methods combine multiple methods
within the atlas based category. This could be a method
which combines deformable registration with a (patch)
pattern recognition approach to minimize the influence
of registrations which resulted in a poor alignment.
The final Hybrid approach combines categories of
the voxel and atlas based approaches. This could for
example be a calculation of two probability density
functions (PDFs) for each voxel; one based on de-
formable registration (atlas) and the other based on
Bayesian statistics (voxel). The two probabilities are
then combined into a unified posterior PDF which
determines the final assignment of CT number to the
voxel [26]. An example of atlas and voxel based sCT
generation for the pelvis and brain can be seen in
Fig. 5.
Performance metrics
Three common metrics reported in the literature to
score the performance of a given sCT generation method
were chosen. The first metric, ΔDose, describes the dosi-
metric agreement when performing dose calculations on
the sCT as compared to the standard CT. This is usually
quantified as the percentage difference in either single
characteristic points, e.g. iso-center or dose prescription
point, or in dose volume histogram (DVH) points. The
general equivalent uniform dose (gEUD) has also been
used to describe the biologically relevant differences of
the entire DVH. Another commonly reported metric for
quantifying dosimetric differences is the gamma index
[36]. This metric covers spatially correlated dose deviation
in both the high and low dose regions. Whenever
differences in multiple dose metrics were reported, e.g.
multiply DVH points, a collectively representative value,
e.g. the mean of all the deviations, was chosen. The second
metric is the mean absolute error (MAE) and describes the
absolute voxel-wise difference in HU defined as
MAE ¼ 1
N
XN
i¼1
CTi−sCTij j
where N is the number of voxels, CT is the standard CT
and sCT is the substitute CT. This metric is typically
lowered as the number of voxel similar to water or air
increases, e.g. moving from the brain to the pelvis or
including air outside the body outline (see Fig. 6a). The
MAE shows a great variation over the different tissue
regions. For the data presented in Fig. 6a, the shown
median MAE of 87 HU for all tissue in the skull covers
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a median MAE of 216, 36 and 261 HU for air, soft tissue
and bone, respectively.
The third metric, the dice similarity coefficient (DSC)
for bone [37], is a geometric score describing the overlap
between the CT and sCT bone volumes. It is defined as
DSCbone ¼ 2 VCT∩V sCTð ÞVCT þ V sCT
where V is the volume of the bone on the CT and substi-
tute CT (sCT), respectively. A similar measure, the Jaccard
coefficient (JAC) can be converted to the DSC through the
relation DSC = 2 · JAC/(1 + JAC) [38]. Another commonly
reported metrics is the sCT specificity and sensitivity for
different tissues such as the bone. The bone DSC,
sensitivity and specificity will depend on the threshold
value set for the CT number of the bone (see Fig. 6b
and c). Other metrics are otherwise noted in the legend
of Table 1.
The performance metrics reported in the literature
cannot be directly compared due to issues such as patient
selection and exclusion criteria which are often
underreported and can introduce a bias. Further, the
amount of preprocessing included in the algorithm such
as data normalization and bias field correction will affect
the final result. Still, methods performing equally well in
the same body region should produce performance
metrics within the same gross interval.
Results
The statistics reported in Fig. 2 and Fig. 3 indicate that
most studies are carried out on the brain for 5-10 pa-
tients with PET/MR applications in mind using a voxel
based method. It is common to use model input data
that coincide with the image data used for the delinea-
tion of the target volume or organs at risk. The main
benefits are avoidance of unnecessary registrations in
the workflow to compensate for intra examination pa-
tient motion and to keep the examination time as short
as possible. Therefore evaluation of T1w input data is
common for the brain region, while T2w input data is
common for the pelvic region. dUTE has the benefit of
enabling separation of cortical bone and air, but has not
been reported useful for delineation purposes. Our
Fig. 5 Examples of sCT generation for the pelvic (top) and brain (bottom). a: An axial CT slice of the pelvic from a prostate patient. b: The
corresponding sCT slice created with an atlas patch based approach [49]. c: An axial CT slice of a brain patient. d: The corresponding sCT slice
created with a voxel Gaussian mixture regression based approach [75]
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review shows that at present point dUTE has only been
evaluated for intra-cranial conditions or phantoms
(Table 1). Dixon based sequences enable separation of
water and fat signal, and is currently often used for at-
tenuation correction of PET data in hybrid PET/MR
scanners. Dixon sequences also tend to be fast and the
in-phase sequence has been reported useful for identifi-
cation of fiducial makers in the prostate [39]. Table 1
shows a wide diversity in terms of the methods and
MRI sequences investigated in the literature. Overall,
the dosimetric agreement is in the order of 0.3–2.5%. A
strict gamma criterion of 1% and 1mm has a range of
passing rates from 68 to 94% while less strict criteria
show pass rates > 98%. Given the relatively small order
of dosimetric disagreement, the residual distortion (i.e.
remaining distortion after applying distortion correc-
tion procedures) present in the MR and hence sCT im-
ages subject to dose calculations seem to be of minor
importance in order to reach an acceptable dosimetric
accuracy. Rather, these seem to be more critical for
accurate target and OAR delineation [40]. The MAE is
between 80 and 200 HU for the brain with a majority
of values lying in the 120–140 HU interval. The MAE
values are around 40 HU for the prostate (pelvis re-
gion). The Dice score for bone is between 0.5 and 0.95
across the different methods, MRI sequences/contrasts
and anatomical sites. The specificity and sensitivity
range from 75 to 98%. As is apparent from Fig. 6c, in-
creasing the specificity will decrease the sensitivity and
vice versa. A compromise seems to be in the upper 80s
for both quantities. Correctly classified voxels average
around 84% for the different methods. No strict rela-
tionship between the dosimetric and geometric agree-
ment as scored by the metrics common in the literature
is present. Further, when a large number of patients are
present in a study, i.e. more than 20 patients, the dice
score seem to be in the lower range (<0.85) of the
reported values probably caused by a larger diversity in
the patient material.
Discussion
Table 1 is not a complete list of all methods used for
generating a sCT, due to the search strategy, time of
search and exclusion criteria applied, some novel
methods such as sparse representation [41] and Random
Forest with auto-context modelling [42, 43] are not in-
cluded. With these limitations in mind, our investigation
shows that sCT generation for MRI-only based radio-
therapy or PET/MRI attenuation correction seems to be
a comprehensively tested area of research given the
Fig. 6 Performance metrics dependence on the region of interest and CT threshold number for the bone. All metrics are calculated on substitute
CTs from 3D T1w MR images of 6 brain patients [47] using an atlas patch based method [48]. a: The boxplot shows the MAE within the body
outline (left) and the whole field of view (FOV, right). The medians were 87 and 49 HU for the body and FOV MAE, respectively, and were
significantly different (p < 0.002). b: The Dice similarity coefficient (DSC) metric for bone as a function of threshold CT number. c: Receiver
operating characteristic (ROC) curve of the sCT bone as a function of CT threshold number (thres). True positive (TP) = sCT > thres & CT > thres,
false positive (FP) = sCT > thres & CT < thres, true negative (TN) = sCT < thres & CT < thres and false negative (FN) = sCT < thres & CT > thres.
Sensitivity = TP/(TP + FN) and specificity = TN/(TN + FP). The threshold was varied from 100 (right) to 3000 (left) HU in steps of 100 HU. Only
voxels > 100 HU on the CT, i.e. the bone region, was included in the evaluation to keep the TN number (non-bone tissue on the sCT and CT) to a
reasonable number
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variety of investigated methods which are able to pro-
duce a sCT from an MRI scan. This presents an advan-
tage in the sense that a broad material is currently
available to further develop on. This strength, however,
also presents a challenge for the field. There is no obvi-
ous method or MRI contrast(s) which seem to be clearly
favorable from the others and hence no clear indication
as to which path of promising methods to pursue. The
data in Table 1do not indicate that inclusion of more
MR contrasts in the generation of the sCT automatically
increase the accuracy. This is encouraging as extra se-
quences both increase the total acquisition time and
overall complexity of the method and the workflow.
Notably, the dice score of the voxel hybrid approaches
using Random Forest (Random F) in Table 1 creates an
almost perfect overlap between CT and sCT bone vol-
umes especially considering the high threshold of 600
HU applied in these studies (see Fig. 6b). These reported
results should encourage other researchers to reproduce
this method on different datasets especially since a pure
Random F approach on dUTE images does not produce
similar high performance scores. The average dosimetric
deviations reported in Table 1 should be used with some
caution. Korsholm et al. reported on dose deviations
using bulk density corrections for multiple treatment
sites [44]. With a bulk density correction for the bone,
the average deviation for median PTV dose of the pros-
tate was practically zero but covers a range of -1.1 to
1.1% representing the 95% confidence interval. They fur-
ther argued that the 95% confidence interval should be
within a 2% dosimetric deviation to produce clinical
acceptable results.
The focus of the present review is the conversion of
image data acquired with MRI to electron density or HU
maps to facilitate a so called MR-only treatment plan-
ning workflow. In addition and not limited to the MR-
only approach, use of MR in radiotherapy requires MR
data with a minimum of geometrical distortions. It has
been shown that distortions due to non-linearity in the
spatial encoding gradients can be successfully corrected
using deterministic algorithms [45], and chemical shift
artifacts and distortions caused by susceptibility effects
can be minimized using a sufficient bandwidth [46].
There is, however, still a need to further confirm these
results and develop efficient quality control techniques,
but this is out of the scope of the current review.
Standardization
One could argue for a need to unify the efforts to localize
promising candidate for sCT generation. A possible way is
to standardize the calculation of the performance metrics
reported in the literature. It is clear from Fig. 6 that the
MAE, DSCbone, specificity and sensitivity metrics have
their limitations and further do not necessarily reflect the
corresponding dosimetric performance of the method.
Quantitative metrics that more unambiguously reflect a
correlation between the geometrical and dosimetrical
agreement are needed and these should further display an
independence of parameters such as selected CT number
threshold and field-of-view. An example could be to score
the sCT-CT difference in bins covering the HU scale inde-
pendent of the number of voxel present in each bin [47].
Another example could be to use differences in radiologic
(water equivalent) path lengths which represent both a
geometric and dosimetric property [48, 49]. The accuracy
of the performance metric should further be related to the
application in question, e.g. RT or PET/MRI. To bench-
mark results, another possible way would be to make
datasets consisting of MRI scans with a variety of con-
trasts and corresponding CT scans for different ana-
tomical sites public available. Such a dataset currently
exists for quantitative imaging of biomarkers [50] and a
similar dataset for sCT generation could serve as a
mandatory step for method benchmarking before publica-
tion. Issues related to the algorithms processing of MRI
signal normalization and correction would further become
apparent on such a dataset. Currently, many studies only
benchmark the sCT against the gold standard CT. In
addition, a dosimetric comparison between a proposed
method and the investigated MRI scan(s) set to water
should be included in a study to give a perspective of the
reported quantities. Another issue is a number of relevant
items which are often not addressed. These cover inclu-
sion or exclusion criteria for the investigated patients
which could create a bias, computation time needed for a
given method to work and restrictions in the possible
clinical implementation of the method.
Clinical implementation
So far, the authors are aware of two institutes which cur-
rently have implemented in-house developed MRI-only
methods clinically. The first institute use a voxel based dual
regression approach on the prostate and have currently
treated around 1502 patients [21, 51]. The second institute
use a voxel based probabilistic approach with fuzzy c-
means on the brain and have currently treated around 30
whole brain and 153 focal brain cases, respectively [52].
Further, commercial solutions for sCT generation are
becoming available [27, 53]. Stereotactic radiosurgery
treatment planning of brain tumors have been carried out
on MRI scans set to water for decades [54]. Brain radiosur-
gery was outside the scope of this review but one could
question this practice given published literature which
demonstrates an improvement in dosimetric accuracy as
compared to a pure water based dose calculation for the
brain, see e.g. [55]. For the brain and other treatment sites,
it has further been shown that a bulk density assignment is
probably sufficient for RT treatment planning [44, 56].
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Treatment delivery and quality assurance (QA) of an
MRI-only based RT workflow are other important issues
which need to be addressed for clinical implementation of
MRI-only RT. In terms of commissioning an MRI-only
workflow, the guidelines as to what tolerances which are
acceptable are limited. As mentioned earlier, a 2% dosimet-
ric agreement between sCT and CT based dose calculation
seems to be of an acceptable order [44] and most of the
investigated methods demonstrate an agreement better
than this. For kV X-ray based image-guided RT (IGRT)
delivery systems, the cone beam CT (CBCT) seems to
provide an acceptable solution for patient setup of both
brain and pelvic patients (marker match is probably suffi-
cient for prostate) [47, 57, 58]. The CBCT can further be
used for patient specific QA of the generated sCT as it
provides an independent estimate of the CT numbers [47].
sCT QA verification efforts using the electronic portal im-
aging device (EPID) has also been proposed [53]. All of the
above elements should be considered when formulating an
MRI-only based RT protocol.
Conclusions
In summary, a variety of promising approaches for substitute
CT generation exist which seem to provide results accept-
able for clinical implementation. This also includes methods
based on clinical simple standard MRI sequences/contrasts.
However, the field suffers from a current lack of an estab-
lished benchmarking method and reporting consistency,
which challenge the commitment from interested vendors
and hence risk a delay for a broad clinical implementation.
Endnotes
1In photon-based RT, the main interest is to convert the
CT number (HU) into an electron density (relative to water)
for dose calculation purposes. Therefore, CT number and
electron density is used interchangeable throughout the text.
2Korhonen J. Personal correspondance. 2015.
3Balter JM. Personal correspondance. 2015.
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